Diastereomerically Pure 6R-and 6S-3′-Aza-2′-18F-Fluoro-5-Methyltetrahydrofolates Show Unprecedentedly High Uptake in Folate Receptor–Positive KB Tumors

SD Boss, C Müller, K Siwowska… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The aim of this study was to develop the radiosyntheses of diastereomerically pure 6 R-and
6 S-3ʹ-aza-2ʹ-18F-fluoro-5-methyltetrahydrofolate (MTHF)(6 R-18F-1 and 6 S-18F-1) using …

Radiosynthesis and Preclinical Evaluation of 3′-Aza-2′-[18F]fluorofolic Acid: A Novel PET Radiotracer for Folate Receptor Targeting

T Betzel, C Müller, V Groehn, A Müller… - Bioconjugate …, 2013 - ACS Publications
The folate receptor (FR) has been identified as a valuable target for the imaging of cancer
and activated macrophages, involved in inflammatory and autoimmune diseases via …

Identification of a PET radiotracer for imaging of the folate receptor-α: a potential tool to select patients for targeted tumor therapy

P Guzik, HY Fang, LM Deberle… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The aim of this study was to identify a folate receptor-α (FRα)–selective PET agent
potentially suitable for the selection of patients who might profit from FRα-targeted therapies …

Reduced 18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging

SD Boss, C Müller, K Siwowska… - Bioconjugate …, 2018 - ACS Publications
5-Methyltetrahydrofolate (5-MTHF), a reduced folate form, is the biologically active folate
involved in many different metabolic processes. To date, there are no studies available in …

A New 18F-Labeled Folic Acid Derivative with Improved Properties for the PET Imaging of Folate Receptor–Positive Tumors

TL Ross, M Honer, C Müller, V Groehn… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The folate receptor is a proven target for folate-based diagnosis and treatment of cancer.
Several folic acid conjugates have been developed as radiopharmaceuticals, but a suitable …

[HTML][HTML] Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy

P Guzik, M Benešová, M Ratz… - European journal of …, 2021 - Springer
Purpose The folate receptor (FR) is frequently overexpressed in a variety of tumor types and,
hence, an interesting target for radionuclide therapy. The aim of this study was to evaluate a …

Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor–positive tumors

A Bettio, M Honer, C Müller, M Brühlmeier… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Folic acid was linked regioselectively through its α-and γ-carboxyl groups to 4-
fluorobenzylamine (FBA), and the α-and γ-FBA-folate regioisomers were evaluated for their …

[18F]Fluoro-Deoxy-Glucose Folate: A Novel PET Radiotracer with Improved in Vivo Properties for Folate Receptor Targeting

CR Fischer, C Müller, J Reber, A Müller… - Bioconjugate …, 2012 - ACS Publications
The folate receptor (FR) is upregulated in various cancer types (FR-α isoform) and in
activated macrophages (FR-β isoform) which are involved in inflammatory and autoimmune …

Novel synthesis and preclinical evaluation of folic acid derivatives labeled with 18F-[FDG] for PET imaging of folate receptor-positive tumors

I Al Jammaz, B Al-Otaibi, S Amer, N Al-Hokbany… - Nuclear medicine and …, 2012 - Elsevier
There is a need to develop more potent radiofluorinated folic acid conjugates for a better
visualization of folate receptors that overexpress on many human cancers. Due to the …

Novel synthesis of [18F]‐fluorobenzene and pyridinecarbohydrazide‐folates as potential PET radiopharmaceuticals

I Al Jammaz, B Al‐Otaibi, S Okarvi… - Journal of Labelled …, 2006 - Wiley Online Library
In an attempt to visualize folate receptors that over‐express on many cancers,[18F]‐
fluorobenzene and pyridine carbohydrazide‐folates were synthesized using two different …